Application of Individualized Treatment for CLL: Novel Agents, Combinations, and Sequencing Therapy

Download All
Learn from the experts about novel agents, combinations, and sequencing therapy for individualized treatment of patients with CLL. Read a ClinicalThought commentary authored by expert faculty and download the clinical resource and slides. Listen to a podcast for answers to FAQs asked during the live Webinar.
Jeremy S. Abramson, MD, MMSc
person default
Brian Hill, MD, PhD
William G. Wierda, MD, PhD

ClinicalThought

How can clinicians best leverage targeted agents to personalize first-line treatment of patients with CLL? Here’s how I individualize therapy based on important factors such as age, comorbidities, presence of del(17p)/TP53 mutation, and IGHV mutation status.

William G. Wierda, MD, PhD Released: October 22, 2020

Clinical Resource

Download this clinician resource to review the current treatment algorithm and key clinical trials in CLL.

William G. Wierda, MD, PhD Released: December 4, 2020

Downloadable Slidesets

Download these slides from our ASH 2020 live satellite symposium on CLL to review the most current clinical data on treating patients with newly diagnosed CLL.

Jeremy S. Abramson, MD, MMSc Released: December 3, 2020

Download these slides from our ASH 2020 live satellite symposium on CLL to review the most current clinical data on treating patients with relapsed/refractory CLL.

person default Brian Hill, MD, PhD Released: December 4, 2020

Download these slides from our ASH 2020 live satellite symposium on CLL to review promising agents and combination therapies currently under investigation in CLL.

William G. Wierda, MD, PhD Released: December 4, 2020

Download this short slideset of key takeaways from a live NCCN/CCO Webinar focused on individualizing treatment in CLL/SLL.

Jeremy S. Abramson, MD, MMSc person default Brian Hill, MD, PhD William G. Wierda, MD, PhD Released: December 9, 2020

FAQ Podcast

Listen to CLL experts William Wierda, MD, PhD, Jeremy Abramson, MD, MMSc, and Brian Hill, MD, PhD, answer audience questions from a live NCCN/CCO Webinar on personalizing therapy for patients with chronic lymphocytic leukemia.

Jeremy S. Abramson, MD, MMSc person default Brian Hill, MD, PhD William G. Wierda, MD, PhD Released: December 23, 2020
Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC.
NCCN Logo

Karen Kanefield
Manager CE Accreditation & Program Operations
National Comprehensive Cancer Network
3025 Chemical Road, Suite 100
Plymouth Meeting, PA 19462

215-690-0239
215-690-0283 (Fax)
education@nccn.org
For Clinicians:
NCCN.org
For Patients:
NCCN.org/patients

Supported by educational grants from
AstraZeneca, Pharmacyclics LLC, an AbbVie Company
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Lilly

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue